Is COMT a susceptibility gene for schizophrenia?

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Catechol-O-methyl transferase (COMT) is an enzyme critical for degrading neurotransmitters like dopamine.
• The COMT gene is located on chromosome 22q11, a region associated with schizophrenia when deleted.
• A common COMT Val/Met polymorphism affects enzyme activity, making it a key candidate for psychiatric research.

Purpose of the Study:

• To review the evidence for and against COMT's involvement in schizophrenia.
• To assess the role of the COMT Val/Met polymorphism in schizophrenia susceptibility.
• To explore complexities in COMT function and its relationship with psychosis.

Main Methods:

• Review of existing genetic and clinical studies on COMT and schizophrenia.
• Analysis of the impact of the COMT Val/Met polymorphism on enzyme activity.
• Consideration of gene-environment interactions and broader genetic regulation of COMT.

Main Results:

• A simple association between the COMT Val/Met polymorphism and schizophrenia is largely excluded.
• Evidence suggests more complex genetic regulation of COMT function beyond the Val/Met locus.
• The relationship between dopamine levels and brain function is nonlinear and complex.

Conclusions:

• While the Val/Met polymorphism alone doesn't explain schizophrenia, COMT's role in psychosis susceptibility cannot be ruled out.
• Complex genetic and neurobiological factors necessitate a nuanced understanding of COMT's involvement in psychiatric disorders.
• Further research accounting for these complexities may clarify COMT's contribution to psychosis risk.